Dermatologist Anthony Chadwick, aka the webinar vet, is offering VetSurgeon members a 30% discount on the cost of a forthcoming series of webinars. Just enter the word vetsurgeon in the discount box at webinarvet.com.
The series kicks off on the 17th June, when John Innes from Liverpool University will be talking about diagnosing forelimb lameness. On the 24th, Alan Robinson will be talking about pet healthcare schemes and on July 1st, Pip Boydell will discuss vestibular disease. Finally, on July 8th, Anthony will close the second series with a look at atopic disease, focusing on new and novel treatments.
For those of you that haven't yet experienced a webinar, and would like to 'try before you buy', there is a free webinar on 10th June (9pm-10pm), in which Martha Cannon, one of only 3 feline specialists in the UK, will present an update on feline infectious disease. Click here to register and if you enjoy the presentation, you will still be able to register for the series at the discounted price.
Intervet/Schering-Plough Animal Health has announced that it is re-introducing Equilis StrepE, the only strangles vaccine for horses in Europe. The vaccine was voluntarily withdrawn from the market in 2007 for stability reasons.
Equilis StrepE, which has already been relaunched in the Netherlands, is now scheduled to arrive in Italy in September and the United Kingdom in October this year. Further re-launches in European countries are scheduled later in 2010 and beyond.
According to Intervet/Schering-Plough, three years of additional research and development have resulted in several improvements to the vaccine, including a better manufacturing process to ensure that the product maintains its characteristics throughout its shelf-life. A more user-friendly applicator has been developed, which enables the needle to slot into place, thereby making it easier to administer the vaccine.
Equilis StrepE is administered through a submucosal injection in the upper lip of the horse and provides immunity for three months following two initial injections, four weeks apart. The vaccine significantly reduces clinical signs of strangles and occurrence of lymph node abscesses in horses that are at risk of infection.
Dr. Peter Daels, veterinarian at the Keros Insemination and Embryo Transfer Center in Beselare (Belgium) said: "In our recipient embryo transfer herd, we have used this strangles vaccine on over 500 mares. After a few applications, the vaccine was easy to administer and did not cause any serious side effects. Despite a steady flow of new horses, only eight cases of strangles were noted - all were mild and most were newly acquired horses that had apparently been exposed shortly before vaccination. I believe that the vaccine provided solid protection against the disease, reduced the severity of clinical cases and eliminated the risk of a widespread outbreak in our herd."
Dr. Roberto Ragni-Alunni, Global Technical Manager Equine at Intervet/Schering Plough Animal Health said: "The re-launch of Equilis StrepE in Europe is an important milestone in our efforts to fully meet the needs of our customers in the equine industry. We continue to work in a very intense and comprehensive way to ensure adequate supply of our equine vaccine range".
For practices planning to take part in National Microchipping Month, Virbac is providing a personalised poster design service and chip promotion throughout June.
According to product manager Gillian Brown, the idea is to offer additional tailored support to practices during the promotional period: "Obviously many practices will have National Microchipping Month materials in place, but the price each practice offers their clients is individual to them. These posters provide a visual platform to highlight the promotion.
"To take advantage of the scheme, practices just need to notify their territory manager of the price they propose to charge and we will then manage the design and print."
Virbac will also be offering a promotional chip price in June to support National Microchipping Month. Gillian said: "Microchipping is now the official means of pet identification approved by the EU Pet Passport Scheme. This will help practices provide an attractive promotion to pet owners and hopefully encourage greater up-take of microchipping."
Any practice interested in the initiative should contact their local Virbac territory manager or call Virbac on 01379 243243.
The Veterinary Medicines Directorate has published the results of the distribution category review, which has recommended the re-classification of 50 products from POM-V or POM-VPS to a less restrictive distribution category.
Not all the products recommended for reclassification will be reclassified, as in some cases, the Marketing Authorisation Holder (MAH) has declined.
MAH will change the distribution category from POM-V to NFA-VPS:Advantage Spot-on Solution for dogs, cats, small cats, small dogs and pet rabbitsDuowinScalibor Protectorband for dogsTop Drop Spot-on Solution for dogs
MAH will change the distribution category from POM-V to POM-VPS:Alpha Ject 2-2Aquavac FNM Plus VaccineAquavac FurovacFurogen 2LactovacLeptavoid HNobilis CAV P4ParacoxParacox 5 oral suspensionRotavec CoronaSpirovacSuvaxyn Ery
MAH will change the distribution category from POM-VPS to AVM-GSL:Coprite
MAH will change the distribution category from POM-V to AVM-GSL:Rearguard
MAH has decided not to change the distribution category from POM-V to NFA-VPSAdvantix Spot-on Solution for dogsFleegard for dogs / cats Frontline Combo spot on for cat and dogFrontline SprayTop Drop
Those Marketing Authorisation Holders that have indicated they are content with the recommendations are required to submit a variation to change the distribution category for the products involved by 30th June 2010, and the variations will come into force at the next label reprint.
For the full report, and a complete list of the affected products, please visit the VMD website here.
The RCVS Trust has announced 34 grants totalling approximately £165,000, being made to veterinary surgeons, universities and higher education (HE) establishments, to fund high-quality research projects in the UK and overseas, and support veterinary education.
Harper Adams University College and Myerscough College will be the first veterinary nursing colleges to receive funding under the Spencer-Hill equipment grants programme; this was the first time that RCVS-approved HE veterinary nurse training providers were able to apply for this funding. Harper Adams will receive £2,350 to purchase a Humphrey ADE-circle system, and Myerscough, £1,395 for an 'Emily' canine positioning mannequin.
Severine Tasker MRCVS, from the University of Bristol, and Janet Patterson-Kane MRCVS, from the University of Glasgow each received Blue Sky Awards of £17,000. Severine will conduct research into constructing defined feline coronavirus strains for determination of the role of virus genetics in the development of feline infectious peritonitis. Janet Patterson-Kane's research will investigate whether a new therapy for treating wounds in humans can be translated for use in horses.
Janet said: "Limb wounds in horses are very common and are notorious for developing masses of exuberant scar tissue - proud flesh - and not healing properly. This can necessitate multiple operations. The findings of current research at University College London by our collaborator, Professor David Becker, suggest that in human patients a protein, connexin 43, is not downregulated at the edges of wounds that are difficult to heal. Use of therapy to reduce connexin 43 expression in human skin wounds in which healing has stalled has been remarkably successful in achieving wound closure. The aim of our research is to determine if connexin 43 plays a similar key role as a 'master switch' for wound healing in horses. I am extremely grateful to the RCVS Trust for their support."
Six veterinary undergraduates will also receive EMS vacation research scholarships of £700 each, which can be used to fund expenses relating to a research project undertaken in the UK or overseas as part of a UK veterinary school's extra-mural studies requirement.
Full details of the RCVS Trust grant awards may be found at www.rcvstrust.org.uk/awards
Following Intervet Schering-Plough's launch of Plerion, a chewable, flavoured wormer for dogs, the company has launched a consumer viral marketing campaign in which they invite pet owners to 'Primp Your Pooch' at the website www.plerion.co.uk.
In the press release, the company says: 'educating clients on worming has never been more fun'. Whilst you might not think that an especially big achievement, it is certainly a polished looking website, and there's a novel competition on the site: owners are invited to upload a photograph of their dog, 'primp' it with a variety of hairstyles and fashion accessories, and then get others to vote for them to win £1000 of luxury spa vouchers.
The launch of Primp Your Pooch follows the award-winning Plerion Showtime web campaign which featured a variety of singing and dancing dogs and achieved an average 1,500 hits a month on the Plerion micro site. Sarah-Jane Minter, marketing Manager at Intervet/Schering-Plough said: "We are always trying to create new and interesting ways to engage with pet owners and have found the web to be a useful platform to drive consumer awareness, as owners enjoy the interactive element that this format offers. The site takes an uninteresting topic and gives it interest to owners. The viral aspect is achieved through social media as consumers are able to share the website with friends via Facebook or email."
As well as an extensive online advertising campaign the Primp Your Pooch campaign will be supported by in practice information. Speak to your local Intervet/Schering-Plough Veterinary Business Manager or phone the company's Veterinary Support Group on 01908 685685 for further information.
CEVA Animal Health is supplying a free, multi-dose injector gun with a self-sterilising needle system, with the purchase of bulk quantities of its luteolytic and uterotonic prostaglandin Enzaprost, while stocks last.
According to the company, the use of naturally occurring prostaglandins such as Enzaprost play an important role in any fertility management programme, working by causing lysis of the corpus luteum. Enzaprost can be used to control the timing of oestrus and synchronisation for AI; for the treatment of sub-oestrus or silent heat; for the induction of abortion up to day 120; for the induction of parturition and as an aid in the treatment of chronic metritis or pyometra where there is a functional or persistent corpus luteum. Natural prostaglandins also have a uterotonic effect which may be useful in the treatment of 'dirty' cows.
CEVA says any multi-cow injection programme has its risks, and that experience has shown that one in 250,000 injections can result in clostridial infection. Invariably this occurs in sequential animals, with the causal agent found in the bottle as a result of inadvertent needle contamination. Multi-dose syringes reduce the number of needle punctures into a bottle and the Sterimatic caps clean the needle before and after each injection helping to minimise the risk of infection. One Sterimatic cap can be used for 72 hours or up to 100 injections. The covered needle also provides increased safety for the operator, resulting in fewer needle stick and scratch injuries.
To find out how you can receive a free multi-dose injector with the Sterimatic needle protector system, which includes five caps and one needle protector, please contact your local CEVA territory manager
For copies of CEVA's fertility newsletters or for further product information please contact the large animal sales team or CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG.
Intervet/Schering-Plough Animal Health has launched a new oxytetracycline spray which the company says offers more accurate antibiotic delivery whether the can is used in an upright or inverted position.
Alasdair King MRCVS, Intervet/Schering-Plough Animal Health veterinary manager, says new Engemycin Spray has been developed specifically to address problems reported with traditional aerosol cans:
"Antibiotic sprays are used widely, yet they can become a practical nuisance to both vets and farmers simply because many cans do not perform satisfactorily. All too frequently the nozzle leaks or detaches, the spray pattern is irregular - particularly if the can is held upside down as it so often needs to be - or the valve clogs before the can is empty. This can be a source of great frustration to users, but new Engemycin Spray overcomes all these problems."
Intervet/Schering Plough says Engemycin Spray combines a unique, quick-drying formulation with an innovative, non-clogging spray valve. The quick-drying formulation minimises wastage from the sprayed area, while the new valve - which works as well when the can is upside down - cuts spraying time and ensures more reliable and constant delivery of antibiotic. The valve is unique and designed to enable the can to fully empty.
Engemycin Spray is licensed for the treatment of foot and wound infections in cattle, sheep or pigs following surgery or physical injury. The new product is available now from wholesalers.
Maverick Television is looking for three veterinary surgeons and two veterinary nurses to front a new Channel 4 television show.
Maverick, makers of Embarrassing Bodies and Bizarre Animal ER, says the new show will be about embarrassing animal behaviours and their bizarre or weird medical conditions.
For further information, contact Laura Wolf on 0121 771 1812, or email her your CV and a recent photograph: l.woolf@mavericktv.co.uk.
Millpledge has launched Promodulate Probiotic Powder, which, according to the company, combines beneficial bacteria with a pre-biotic, vitamins and electrolytes to rebalance gut flora, fluid and electrolyte balance in cats and dogs.
The powder is presented in a 5 day course of sachets for ease of dispensing, or in a 50g tub for longer term use.
Millpledge says micro-encapsulated Entrococcus Faecium SF68 NCIMB 10415 - 667 x 106 CFU/g helps to recolonise the gut and maintain competitive exclusion of harmful bacteria whilst the preferred prebiotic Fructooligosaccharide (FOS) provides a targeted source of sugars to fuel the Entrococcus Faecium. Electrolytes are included to help maintain the isotonic fluid balance in the patient, and vitamins to maintain the normal feed conversion ability of the gut to absorb and bind nutrients present in the diet.
Millpledge suggests that Promodulate is beneficial alongside antibiotic therapy and can be used as an aid to maintaining the immune response in newborns as well as animals in the later stages of life. Promodulate is also recommended as an aid to restoring normal digestive function and to help maintain normal cholesterol levels and electrolyte and fluid balance.
For more information, please click here.
A team of researchers at the Royal Veterinary College have discovered that many-legged animals control their movement in a surprisingly different way to bipedal animals, following a study on cockroaches using tiny accelerometers and advanced computer models.
The study, published in the Journal of Experimental Biology (JEB) on 14 May 2010, found that four or more legged creatures do not adjust for hard or soft surfaces in the same manner as humans.
The RVC says the results were surprising because past work had found that running and trotting animals with four-, six-, or eight legs exert forces on the ground that look remarkably similar to two-legged humans.
The study used cockroaches with tiny accelerometer backpacks as the basis of the research before developing advanced computer models to further the findings.
The accelerometers were developed by Andrew Spence while working in the Poly-PEDAL laboratory of Professor Bob Full at the University of California, Berkeley. Dr. Spence, now following up the research as a Research Council UK (RCUK) research fellow at the RVC, along with his colleague Shai Revzen, attached the device to the cockroaches' back before sending the insects scuttling across a sheet of latex.
The cockroach sank into the soft rubber surface, like humans sink into the mud, but was able to maintain their forward speed, despite the extremely soft going.
Dr. Spence said: "Like humans, four or more legged animals move as if they are bouncing on a virtual pogo stick when running on hard surfaces. However, when humans run over soft surfaces, they effectively "stiffen" their virtual 'pogo stick', so we were keen to discover if this was the same for four or more legged animals."
Following the initial study, a computer-generated model cockroach was developed to help explain how the insect ran on, and sunk into, soft ground, with the 'cyber-roach' confirming earlier findings.
From the 'cyber-roach' the researchers concluded that instead of maintaining the body's centre of mass motion by stiffening the virtual pogo stick leg like human runners, the insect does not change the stiffness of its virtual pogo stick. The reason that the insect is able to run successfully without crashing, despite using the "wrong" leg stiffness, may be due to the change in posture that occurs when a legged animal sinks into a surface, as the legs that are flying through the air hit the ground sooner than they normally would.
Dr. Spence believes this simplifies the task for the nervous system: "Instead of sending nervous system signals to stiffen muscles, the cockroach may just be able to continue sending the same control signals and take advantage of this change in posture."
Vetoquinol is offering vets the opportunity to win one of five Selekt Cattle Pumps worth £240. In order to take part, you'll need to tell Vetoquinol about your experiences with Marbocyl 10% when treating acute mastitis.
Susan Mitchell, Vetoquinol's Large Animal Product Manager said: "This case study competition aims to gather information on the incidence and treatment of acute mastitis. Acute mastitis is a genuine veterinary emergency and rapid treatment is vitally important."
Vetoquinol says Marbocyl 10% has proven to be an effective treatment for acute E.coli mastitis, with a bactericidal action which does not liberate endotoxins. Administered intravenously, Marboyl 10% provides rapid improvement and an early return to milk production.
The company also says farmers have found toxaemic mastitis cases have benefited from the use of fluid therapy, using the Selekt Cattle Pump. Oral fluid therapy is a quick, easy and inexpensive option to intravenous treatment and improves the efficacy of hypertonic saline.
To enter the competition, visit http://www.vetoquinol.co.uk/, click the Marbocyl link on the right, and download and complete a brief case history.
Five winners will be chosen at random on 30th June 2010.
Norbrook Laboratories Ltd has launched a new addition to the Loxicom range: Loxicom 0.5mg/ml Oral Suspension for Cats.
Offering alleviation from inflammation and pain, Loxicom Oral Suspension for Cats is billed by Norbrook as 'the new cost-effective treatment for chronic musculo-skeletal disorders in cats that is bio-equivalent to the pioneer.'
The Loxicom range now offers vet practices a choice between 5mg/ml Solution for Injection for Dogs and Cats, 1.5mg/ml Oral Suspension for Dogs and now 0.5mg/ml Oral Suspension for Cats.
Loxicom Oral Suspension for Cats is available in a clear 15ml bottle allowing veterinary surgeons and their clients to monitor product levels and re-order when necessary. The packaging also includes a graduated syringe in 0.5kg increments (from 0.5-10kg) which plugs securely into the bottle allowing accurate, mess-free administration.
Norbrook's small animal range also includes Carprieve, a range of carprofen tablets and injection and Noroclav, the amoxycillin / clavulanic acid range of tablets and injection.
Vetoquinol has introduced a new smaller pack size for Reprocine, to help prevent wastage. The new 6 x 10ml pack is now available from wholesalers.
Reprocine is licensed in the cow for uterine atony during the puerperal (post-parturient) period, placental retention as a consequence of uterine atony and initiation of milk ejection in a stress-induced agalactia or in conditions requiring udder emptying. In the sow, Reprocine is licensed for uterine atony during the puerperal period also, supportive therapy of mastitis-metritis-agalactia (MMA) syndrome, initiation of milk ejection and for shortening of parturition period. Reprocine is an intraveneous or intramuscular injection and has the added advantage of no milk or meat withdrawal.
Susan Mitchell, Vetoquinol's Large Animal Product Manager said: "The new pack size reduces wastage which provides an instant cost-effective advantage.
"Reprocine is rapidly distributed and slowly eliminated. Efficient parturition and milk ejection is essential for newborn welfare and ultimately provides an economic benefit. Reprocine can be utilised in many reproductive associated conditions."
Reprocine is also available in 50ml bottles.
A survey of more than 4,000 members of the public by the Pet Food Manufacturers' Association (PFMA) has revealed that 90% of people think that separation from a pet is traumatic for older people entering residential care or sheltered accommodation.
The TNS research carried out in March 2010 also found 83% agree pets make their owners happier and 54% think pet owners should be able to make the choice about entering care facilities after seeing the accommodation policy.
According to the PFMA, the benefits of pet ownership for elderly people include a lower risk of heart attack and stroke, reduced blood pressure and cholesterol, improved recovery from heart attacks and strokes, better social interactions in people with dementia, and fewer GP visits. In addition, those who keep pets when entering care homes enjoy a smoother transition into residential care,
The PFMA says this survey has helped shape its goal to ensure all leading UK housing providers implement responsible pet policies that enable older people to make an informed choice about their future. This commitment is part of the organisation's 2020 vision to 'make a better world with pets', launched to mark its 40th anniversary.
The PFMA also says it is working closely with SCAS (Society for Companion Animal Studies) and MPs - including Ian Cawsey, Nick Palmer and Nigel Waterson - all striving for fairer treatment of the older pet-owning public.
Ian Cawsey, MP for Brigg and Goole, said: 'Today we have more than 11 million elderly adults living in Britain, of whom approximately 25% are pet-owners. This figure is estimated to rise to 14 million by 2026 and the majority of these people will eventually require some form of residential care. Unfortunately growing older often involves inevitable heartache and loss but being separated from a pet when entering care facilities should not be part of it. This is why I welcome the PFMA's 2020 goal to ensure care facilities implement responsible pet policies over the next decade."
PFMA, Chief Executive, Michael Bellingham, explains: "Having analysed the research and consulted SCAS we are delighted to announce our 2020 ambition to ensure fairer treatment of the older pet-owning public. The importance of pets to people in care facilities cannot be under-estimated. Over the next ten years we want to make a big difference to the lives of older pet owners."
This latest call to action follows the successful passing of shadow minister for older people, Nigel Waterson's bill - Care Homes and Sheltered Accommodation (Domestic Pets) Bill - which aims for a more "enlightened and responsible" policy for allowing pet owners in residences to keep their beloved animals.
Bayer Animal Health reports that sales of Drontal have achieved double digit growth following the company's recent advertising campaign.
The company says its marketing push has been so successful that 83% of cat and dog owners now name Drontal ahead of any other wormer.
Apparently, vet practice waiting room posters are most commonly the way pet owners learn about Drontal, while approximately half of those regularly tuning in to the popular TV series The Dog Whisperer and GMTV were aware of Drontal's sponsorship of the programmes.
Dan White, Drontal's product manager said: "Bayer has invested heavily in advertising Drontal direct to pet owners effectively driving them into veterinary practice and producing accompanying practice support materials such as waiting room posters and wormer reminder cards which have really paid off. Three-quarters of pet owners surveyed stated they last purchased their wormer from their veterinary practice," comments.
"We will continue to support veterinary practices through advertising and sponsorship initiatives to help raise awareness of the importance of regularly worming pets with Drontal and boost sales further."
For further information or to order more Drontal practice support materials, please contact your local Bayer territory manager.
CEVA Animal Health, manufacturer of the veterinary behaviour products Feliway and D.A.P., has launched a guide to the practical applications of pheromones.
The 80 page book, entitled 'D.A.P.® and Feliway® Papers and Abstracts', features details of 31 published trials. It includes an introduction to pheromonatherapy by veterinary behaviourist, Sarah Heath, and covers research into the use of pheromones for a wide range of behavioural issues in both dogs and cats, including feline urine marking, feline lower urinary tract disease (FLUTD), the introduction of new pets to a household, noise phobias and firework fears, and puppy socialisation and adoption.
The guide contains an overview of each behavioural issue, and details of the trials and recommendations on the use of Feliway® or D.A.P.® to help prevent and control the problem.
Lucy Brett, product manager at CEVA Animal Health said: "There is considerable data supporting the use of Feliway® and D.A.P. ®. The reference guide brings together this research into one comprehensive handbook which is a must for veterinary professionals interested in feline and canine behaviour."
For a copy of the D.A.P.® and Feliway® Papers and Abstracts reference guide, please contact your CEVA Animal Health representative or call 01494 781510.
A one-day seminar entitled ‘One World, One Disease,’ will take place at the Royal Society of Medicine (RSM), Wimpole Street, London, on 24 June 2008.
The event, which has been jointly organised by the RSM and the Royal College of Veterinary Surgeons (RCVS), will examine some of the effects of climate change on patterns of animal health and the impact of this on humans. The meeting will provide an understanding of the complexity of the global changes that we face, and will work towards the integrated approach needed to manage the serious problems that threaten animal and human health.
About two-thirds of new infectious diseases that threaten humans come from animals. With global climate change, this looks set to increase. Now more than ever, it is important that veterinary and medical colleagues come together to discuss disease control strategies.
Speakers will include RCVS Senior Vice-President Professor Sheila Crispin, who has been instrumental in organising the conference, Caroline Lucas MEP, Professor Bob Watson, Defra’s Chief Scientific Adviser, the RVC’s Professor Quintin McKellar and Lt Col Tim Brookes from the Health Protection Agency, among others.
All are welcome. Tickets are available from the Royal Society of Medicine online at http://www.rsm.ac.uk/academ/e10-oneworld.php
Here’s a gadget I’d love to get my hands on: the Zoombak advanced GPS pet locator, launched in the UK today.
The locator attaches to any dog collar, or indeed your car, husband, wife or teenager, and allows you to get a real time fix of their location by telephone, or on your computer. It costs £99.99 from pet retailers, with an additional £9.99 per month service subscription (£99.99 if paid annually upfront), which allows for an unlimited number of ‘locates’. Hot on its heels comes the Pawtrack, which will also cost £99.99 with a similar monthly subscription which allows for 1200 locates per month.
Pawtrack is being aimed at both cats and dogs, and whilst it is marginally smaller and lighter than the Zoombak, there isn’t a lot in it. Both are still probably too cumbersome for a cat, which is why Zoombak more pragmatically recommends its product for dogs over 7 kg.
Doubtless it won’t be long before they miniaturise the technology so that it’ll be the width of a nostril hair, thereby solving the problem of pet theft and loss completely. Meantime, these look like a practical and fun gadget for the owners of larger breeds that regularly go AWOL.
For more information on stocking Zoombak please contact Zoombak on 08708 033095.
Colivet® solution, one of CEVA Animal Health’s range of 3 soluble antimicrobials for pigs has been renamed Coliscour®.
Phil McGuire, CEVA’s business unit manager, explains the reasoning behind the name change: “We simply felt that the easiest way to avoid confusion between our product and a totally different non-prescription product of a similar name was to give ours a new name that also reflects its use, hence Coliscour®.”
Beechwood Veterinary Hospital has become the first (and only) place in the country where dogs and people can give blood.
The Doncaster vets has teamed up with the National Blood Service (NBS) and Pet Blood Bank UK (PBBuk) to offer the community the chance to help with these worthy causes.
Mark Straw, veterinary surgeon and associate director said: "I'm a regular blood donor and know how important it is to give. I thought it would be a great if I could do it at work, luckily enough so did the other staff and the owners of our patients. I am proud that Beechwood is now a people and pets lifesaver."
Mark added: "Once we were on the way to arranging our first NBS visit one of the dogs we were treating needed a transfusion so we made some calls and our first canine session takes place in May".
Craig Taylor, spokesperson for the NBS, said: "This is a real first for the country and it is happening here in Doncaster. It just goes to show how generous all it's residents are, I'm sure they will have as much support from their doggy donors as well."
"We would like to thank everyone who gave and everyone at hospital for making us so welcome."
Genitrix has launched Dentagen, billed as the UK’s first dental plaque protection system for dogs and cats.
The active principle in Dentagen is a plant extract called RF2 and the product operates as an ‘anti-biofilm’ treatment by modifying the membrane of oral bacteria to prevent them from producing plaque even at low concentrations.
Dentagen wax is presented for practice use in a syringe for easy application to the gingival layer and the buccal area of teeth. The initial protective coating of wax is applied to dogs or cats at end of dental procedures in practice and while the animal is still sedated. The coating lasts for two to three days.
Dog owners can then maintain the protective coating by giving their pet Dentagen plaque prevention chews every other day. The chews, impregnated with RF2 and of a specially designed shape and consistency, are supplied in two sizes with the larger size designed for dogs over 8 kg and a smaller size for dogs less than 8 kg.
Vet Katy Horton of White Hart Lane Vets, who has trialled the product, commented: “The Dentagen wax was certainly very easy to apply and, from the small sample of dogs we’ve so far tried it on, the palatability of the chews was good. While tooth-brushing remains the gold standard for dental care, we recognise that it can be difficult for owners and believe that this new approach could be a valuable alternative.”
Five syringes of Dentagen for application in practice cost £12.50. Packs of nine small chews cost £5.10 while a pack of the larger chews costs £6.50.
Intervet has announced that its bluetongue vaccine, Bovilis® BTV8 has been granted a licence by the Veterinary Medicines Directorate (VMD). The licence, which is the first for a bluetongue vaccine in the UK, sets out dose rates and treatment regimes for the product use.
The recommended dose rates for animal over one month of age are as follows:
Sheep – 1 x 1ml, injected subcutaneously.
Cattle - 2 x 1ml, approximately three weeks apart, injected subcutaneously.
In successive years, re-vaccination should be given two weeks prior to the risk period.
Treated animals should have protective immunity three weeks after the initial course. Bovilis BTV8 should only be administered to healthy animals. Treated stock may have a slight swelling at the site of injection.
The vaccine must be stored at between 2ºC – 8ºC and, once opened, should be used within eight hours. The vaccine is available in 20ml and 50ml bottles. The licence recommends the use of multi injection vaccination systems.
Intervet will be supplying a discounted 1ml vaccination gun into the market.
Kruuse UK has expanded the well-known Buster range of “elizabethan” collars with the introduction of a Buster Comfort Collar. This new design is softer and more flexible and features a soft rubber outer edge for better comfort for the animal and is kinder to its surroundings.
Kruuse says prolonged use can make the edges of strong, rigid plastic collars brittle and ragged, especially with active animals, which is why the Comfort Collar was developed to alleviate this problem in such situations. Manufactured out of environmentally-friendly 100 per cent polypropylene, these collars still feature the quick-fastening system found on the Buster Clic Collar and are fully transparent to allow the animal all-round vision. The Buster Comfort Collars are available in seven sizes ranging from 7.5 to 30cm. For further information, please contact: Andrew Groom, Country Manager, Kruuse UK Ltd. Telephone: +44 (0) 1977 681523. E-mail: andrew.groom@kruuse.com.
RIP Fleas, the environmental flea treatment from Genitrix, has been given a new formulation to ensure it acts more quickly in the killing of adult fleas and that it continues to kill fleas as they emerge from pupae for up to 12 months.
Now known as RIP Fleas Extra, the product is also licensed for the control of house dust mites in the environment for up to 12 months.
According to Genitrix, the reformulation makes RIP Fleas Extra the only environmental flea treatment to contain three active ingredients while complying fully with new EU Biocides regulations. It is the only such treatment to be fragranced and is also the only product to be presented in a volume which will cover 120 square metres – ie the size of an average house. RIP Fleas Extra contains:
Tetramethrin – a second generation synthetic pythrethroid and a contact insecticide with a rapid knockdown action of insect pests
Permethrin – a potent insecticide with a powerful contact action on insects but with a low toxicity to most mammals
Methoprene – a compound that mimics the insect juvenile hormone and arrests development of fleas and house dust mites in the environment.
When used synergistically, Tetramethrin and Permethrin provide a rapid knockdown and kill of fleas as they hatch from pupae. Studies have shown that this combination works four times more quickly than Permethrin alone.